[DOI] [PubMed] [Google Scholar] 2.Wedlake L, A'Hern R, Russell D, et al
The committee has agreed further lists of questions to be addressed by the respective marketing authorisation holders for these medicines. In July 2023, the MHRA launched its own review into the risk of suicidal thoughts and thoughts of self-harm associated with GLP-1 RAs
To learn more about GLP-1 trends, including the market for new oral and generic medications, and how to engage with GLP-1 households, click the link to watch the webinar, co-hosted by Sally Lyons-Wyatt and Daniel Joyner
Related Stories Lactoferrin yogurt helps preserve iron stores in women with gestational diabetes GLP-1 receptor agonists may increase hair loss risk Medically tailored grocery deliveries improve blood sugar control among diabetes patients Each decile calibration was based on comparing mean projected CATE estimations to mean HbA1c differences in people taking SGLT2i versus GLP1-RA
You meet formulary requirements under your Aetna plan
Individual results vary depending on diet, activity level, and overall health
